Lansdale, PA, United States of America

Matthew Woodling

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Woodling. Retrieved from https://idiyas.com/inventor/matthew-woodling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew Woodling

Introduction

Matthew Woodling is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of virology through his innovative patents. With a total of 2 patents, Woodling's work focuses on improving processes related to the purification of viruses and vaccine production.

Latest Patents

One of Woodling's latest patents is titled "Scalable chromatography process for purification of human cytomegalovirus." This invention relates to a scalable process for purifying human cytomegalovirus particles from cell culture medium. The process involves a two-step chromatography method, starting with an anion exchange chromatography step, followed by a polishing chromatography step selected from mixed mode chromatography or cation exchange chromatography.

Another significant patent by Woodling is "Addition of nucleases directly to cell culture to facilitate digestion and clearance of host cell nucleic acids." This invention provides an efficient process for culturing viruses in the presence of an endonuclease. It aims to produce vaccines, typically from live attenuated viruses, under conditions that reduce the presence of host cell DNA and eliminate the need for a post-harvest DNA digestion step.

Career Highlights

Matthew Woodling is currently employed at Merck Sharp & Dohme Corp., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficiency of viral purification and vaccine production processes.

Collaborations

Woodling collaborates with talented coworkers, including Adam Kristopeit and Janelle Konietzko. Their combined expertise contributes to the innovative environment at Merck Sharp & Dohme Corp.

Conclusion

Matthew Woodling's contributions to virology through his patents demonstrate his commitment to advancing medical science. His innovative approaches to virus purification and vaccine production are paving the way for more efficient and effective healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…